Auther

Year

Country

Genotype

method

SOC

Ethnicity

Cancer

type

Case

Control

HWE

NOS

TT

AT

AA

TT

AT

AA

P-value

Wang [9]

2017

China

PCR

HB

Chinese

BC

317

207

36

338

202

42

0.13

8

Fard [10]

2018

Iran

RFLP-PCR

PB

Iranian

BC

96

65

42

106

74

23

0.08

6

Chang [17]

2014

china

PCR

HB

Chinese

RCC

29

48

15

285

191

104

<0.01

5

Bau [20]

2011

china

RFLP-PCR

HB

Chinese

OC

363

193

64

306

206

108

<0.01

8

Hsu [12]

2013

china

RT-PCR

HB

Chinese

HCC

166

93

39

152

98

48

<0.01

5

lin [13]

2014

china

RFLP-PCR

HB

Chinese

GC

188

135

35

192

133

33

0.16

5

liu [11]

2011

China

RFLP-PCR

HB

Chinese

BC

745

410

77

694

472

111

0.02

5

Sugie [16]

2013

japan

RFLP-PCR

HB

Japanese

PC

60

63

11

25

42

19

0.86

6

Wang [27]

2014

China

RFLP-PCR

HB

Chinese

ESCC

259

143

25

221

166

40

0.28

5

chang [17]

2013

China

RFLP-PCR

HB

Chinese

UUTC

140

65

13

303

224

53

0.21

5

Yang [14]

2010

China

RFLP-PCR

HB

Chinese

CRC

216

117

29

179

120

63

<0.01

7

Tsou [21]

2011

China

RFLP-PCR

HB

Chinese

NPC

109

55

12

86

57

33

<0.01

5

Zhang [15]

2014

chian

RFLP-PCR

HB

Chinese

GC

239

134

39

210

136

66

<0.01

6

bau [18]

2011

chian

RFLP-PCR

HB

Chinese

bladder cancer

231

122

22

198

142

35

0.2

6

wu [19]

2011

chian

RFLP-PCR

HB

Chinese

PC

163

75

12

254

196

50

0.18

6

Wang [22]

2013

chian

RFLP-PCR

HB

Chinese

leukemia

167

86

13

140

99

27

0.14

6